✦ LIBER ✦

Low-Molecular-Weight Heparin Versus Placebo for the Prevention of Venous Thromboembolism in Metastatic Breast Cancer or Stage III/IV Lung Cancer

✍ Scribed by Haas, S. K.; Freund, M.; Heigener, D.; Heilmann, L.; Kemkes-Matthes, B.; Tempelhoff, G.-F. v.; Melzer, N.; Kakkar, A. K.

Book ID: 127340519
Publisher: SAGE Publications
Year: 2012
Tongue: English
Weight: 190 KB
Volume: 18
Category: Article
ISSN: 1076-0296
DOI: 10.1177/1076029611433769

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Low-Molecular-Weight Heparin versus a Co

Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer

✍ Lee, Agnes Y.Y.; Levine, Mark N.; Baker, Ross I.; Bowden, Chris; Kakkar, Ajay K. 📂 Article 📅 2003 🏛 Massachusetts Medical Society 🌐 English ⚖ 108 KB

Low-molecular-weight heparin vs. a couma

Low-molecular-weight heparin vs. a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer

✍ A.Y.Y. Lee; M.N. Levine; R.I. Baker 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 46 KB

3001 POSTER DISCUSSION Ultra-low-molecul

3001 POSTER DISCUSSION Ultra-low-molecular-weight Heparin (ULMWH) Semuloparin for Prevention of Venous Thromboembolism (VTE) in Cancer Patients Receiving Chemotherapy: Consistent Beneficial Effect Across Cancer Stage and Location Subgroups

✍ G. Agnelli; D. George; W.D. Fisher; A.K. Kakkar; M.R. Lassen; P. Mismetti; P. Mo 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB